CL
CELG

CFS LLC’s Celgene Corp CELG Stock Holding History

CFS LLC’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,963
Closed -$332K – 47
2014
Q4 		$332K Buy
2,963
+97
+3% +$10.2K 0.48% 29
2014
Q3 		$272K Buy
2,866
+1,538
+116% +$139K 0.23% 44
2014
Q2 		$114K Sell
1,328
-76
-5% -$5.78K 0.09% 52
2014
Q1 		$98K Buy
1,404
+422
+43% +$33.4K 0.09% 59
2013
Q4 		$83K Hold
982
– – 0.08% 65
2013
Q3 		$73K Hold
982
– – 0.07% 62
2013
Q2 		$57K Buy
+982
New +$59.1K 0.05% 71

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CFS LLC's CELG Position: Q1 2015 in Review

CFS LLC sold out of Celgene Corp (CELG) in Q1 2015, closing a stake of 2,963 shares — an estimated $332K sold.

CFS LLC first reported a position in CELG in Q2 2013 and held it in 7 quarters. The position peaked at $332K in Q4 2014. 1,193 funds tracked by Wall St. Rank hold CELG as of Q1 2015.

  • CFS LLC reported no remaining Celgene Corp position as of Q1 2015 after selling out during the quarter.
  • CFS LLC sold 2,963 Celgene Corp shares in Q1 2015, an estimated $332K.
  • CFS LLC first reported a position in Celgene Corp in Q2 2013 and held it in 7 quarters.
  • CFS LLC's Celgene Corp position peaked at $332K in Q4 2014.
  • 1,193 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2015.

Based on CFS LLC's 13F filing for Q1 2015, filed 15 May 2015.